Analysis of gene expression changes in a cellular model of Parkinson disease

Neurobiology of Disease

Volumn 18, Issue 1, 2005, Pages 54-74

  Ryu, Elizabeth J ^a,b   Angelastro, James M ^b   Greene, Lloyd A ^a,b  

^a New York NY 10032 United States ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

6 hydroxydopamine; Apoptosis; Cell cycle; Endoplasmic reticulum stress; Gene expression; Oxidative stress; Parkinson disease; Proteasome; SAGE; Unfolded protein response

Indexed keywords

OXIDOPAMINE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE INDUCTION; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SERIAL ANALYSIS OF GENE EXPRESSION; UNINDEXED SEQUENCE;

ANIMALS; CELL CYCLE; CELL DEATH; CELL DIFFERENTIATION; CELL SURVIVAL; DOPAMINE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; NERVE DEGENERATION; NERVE GROWTH FACTOR; NERVE TISSUE PROTEINS; NEURONS; OXIDATIVE STRESS; OXIDOPAMINE; PARKINSON DISEASE; PC12 CELLS; PROTEIN FOLDING; RATS; TRANSCRIPTION FACTORS;

EID: 11844287697     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2004.08.016     Document Type: Article

References (165)

1. P. Agostinho, and C.R. Oliveira Involvement of calcineurin in the neurotoxic effects induced by amyloid-beta and prion peptides Eur. J. Neurosci. 17 2003 1189 1196
2. A. Alcivar, S. Hu, J. Tang, and X. Yang DEDD and DEDD2 associate with caspase-8/10 and signal cell death Oncogene 22 2003 291 297
3. T. Andoh, P.B. Chock, and C.C. Chiueh The roles of thioredoxin in protection against oxidative stress-induced apoptosis in SH-SY5Y cells J. Biol. Chem. 277 2002 9655 9660
4. J.M. Angelastro, L. Klimaschewski, S. Tang, O.V. Vitolo, T.A. Weissman, L.T. Donlin, M.L. Shelanski, and L.A. Greene Identification of diverse nerve growth factor-regulated genes by serial analysis of Gene Expression (SAGE) profiling Proc. Natl. Acad. Sci. U. S. A. 97 2000 10424 10429
5. A. Asai, J. Qiu, Y. Narita, S. Chi, N. Saito, N. Shinoura, H. Hamada, Y. Kuchino, and T. Kirino High level calcineurin activity predisposes neuronal cells to apoptosis J. Biol. Chem. 274 1999 34450 34458
6. J. Bai, H. Nakamura, I. Hattori, M. Tanito, and J. Yodoi Thioredoxin suppresses 1-methyl-4-phenylpyridinium-induced neurotoxicity in rat PC12 cells Neurosci. Lett. 321 2002 81 84
7. K. Banki, E. Hutter, E. Colombo, N.J. Gonchoroff, and A. Perl Glutathione levels and sensitivity to apoptosis are regulated by changes in transaldolase expression J. Biol. Chem. 271 1996 32994 33001
8. D.E. Baranano, M. Rao, C.D. Ferris, and S.H. Snyder Biliverdin reductase: a major physiologic cytoprotectant Proc. Natl. Acad. Sci. U. S. A. 99 2002 16093 16098
9. M.F. Beal Mitochondria, oxidative damage, and inflammation in Parkinson's disease Ann. N. Y. Acad. Sci. 991 2003 120 131
10. E.B. Becker, and A. Bonni Cell cycle regulation of neuronal apoptosis in development and disease Prog. Neurobiol. 72 2004 1 25
11. D. Berg, O. Riess, and A. Bornemann Specification of 14-3-3 proteins in Lewy bodies Ann. Neurol. 54 2003 135
12. R. Betarbet, T.B. Sherer, G. MacKenzie, M. Garcia-Osuna, A.V. Panov, and J.T. Greenamyre Chronic systemic pesticide exposure reproduces features of Parkinson's disease Nat. Neurosci. 3 2000 1301 1306
13. L.A. Bindoff, M.A. Birch-Machin, N.E. Cartlidge, W.D. Parker Jr., and D.M. Turnbull Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease J. Neurol. Sci. 104 1991 203 208
14. D. Blum, Y. Wu, M.F. Nissou, S. Arnaud, B. Alim Louis, and J.M. Verna p53 and Bax activation in 6-hydroxydopamine-induced apoptosis in PC12 cells Brain Res. 751 1997 139 142
15. D. Blum, S. Torch, M.F. Nissou, A.L. Benabid, and J.M. Verna Extracellular toxicity of 6-hydroxydopamine on PC12 cells Neurosci. Lett. 283 2000 193 196
16. J.C. Bourdon, J. Renzing, P.L. Robertson, K.N. Fernandes, and D.P. Lane Scotin, a novel p53-inducible proapoptic protein located in the ER and the nuclear membrane J. Cell Biol. 158 2002 235 246
17. A.I. Brooks, C.A. Chadwick, H.A. Gelbard, D.A. Cory-Slechta, and H.J. Federoff Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss Brain Res. 823 1999 1 10
18. J.L. Cadet, M. Katz, V. Jackson-Lewis, and S. Fahn Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats: behavioral and biochemical evidence Brain Res. 476 1989 10 15
19. R. Casagrande, P. Stern, M. Diehn, C. Shamu, M. Osario, M. Zuniga, P.O. Brown, and H. Ploegh Degradation of proteins from the ER of S. cerevisiae requires an intact unfolded protein response pathway Mol. Cell 5 2000 729 735
20. R. Castellani, M.A. Smith, P.L. Richey, and G. Perry Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease Brain Res. 737 1996 195 200
21. M.V. Catania, A. Copani, A. Calogero, G.I. Ragonese, D.F. Condorelli, and F. Nicoletti An enhanced expression of the immediate early gene, Egr-1, is associated with neuronal apoptosis in culture Neuroscience 91 1999 1529 1538
22. E. Chalaux, T. Lopez-Rovira, J.L. Rosa, G. Pons, L.M. Boxer, R. Bartrons, and F. Ventura A zinc-finger transcription factor induced by TGF-beta promotes apoptotic cell death in epithelial Mv1Lu cells FEBS Lett. 457 1999 478 482
23. S. Chatterjee, K. Zaman, H. Ryu, A. Conforto, and R.R. Ratan Sequence-selective DNA binding drugs mithramycin A and chromomycin A3 are potent inhibitors of neuronal apoptosis induced by oxidative stress and DNA damage in cortical neurons Ann. Neurol. 49 2001 345 354
24. T.S. Chen, E. Koutsilieri, and W.D. Rausch MPP+ selectively affects calcium homeostasis in mesencephalic cell cultures from embryonal C57/Bl6 mice J. Neural Transm.: Gen. Sect. 100 1995 153 163
25. M.C. Chen, M.J. Hwang, Y.C. Chou, W.H. Chen, G. Cheng, H. Nakano, T.Y. Luh, S.C. Mai, and S.L. Hsieh The role of apoptosis signal-regulating kinase 1 in lymphotoxin-beta receptor-mediated cell death J. Biol. Chem. 278 2003 16073 16081
26. W.S. Choi, D.S. Eom, B.S. Han, W.K. Kim, B.H. Han, E.J. Choi, T.H. Oh, G.J. Markelonis, J.W. Cho, and Y.J. Oh Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8- and-9-mediated apoptotic pathways in dopaminergic neurons J. Biol. Chem. 279 2004 20451 20460
27. W. Dauer, and S. Przedborski Parkinson's disease: mechanisms and models Neuron 39 2003 889 909
28. T.M. Dawson, and V.L. Dawson Molecular pathways of neurodegeneration in Parkinson's disease Science 302 2003 819 822
29. M.J. Del Rio, and C. Velez-Pardo Monoamine neurotoxins-induced apoptosis in lymphocytes by a common oxidative stress mechanism: involvement of hydrogen peroxide (H(2)O(2)), caspase-3, and nuclear factor kappa-B (NF-kappaB), p53, c-Jun transcription factors Biochem. Pharmacol. 63 2002 677 688
30. J. Dierov, M. Prosniak, G. Gallia, and R.B. Gartenhaus Increased G1 cyclin/cdk activity in cells overexpressing the candidate oncogene, MCT-1 J. Cell. Biochem. 74 1999 544 550
31. D.A. Di Monte The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins? Lancet Neurol. 2 2003 531 538
32. M. Dohn, J. Jiang, and X. Chen Receptor tyrosine kinase EphA2 is regulated by p53-family proteins and induces apoptosis Oncogene 20 2001 6503 6515
33. G.P. Dotto p21(WAF1/Cip1): more than a break to the cell cycle? Biochim. Biophys. Acta 1471 2000 M43 M56
34. W. Duan, X. Zhu, B. Ladenheim, Q.S. Yu, Z. Guo, J. Oyler, R.G. Cutler, J.L. Cadet, N.H. Greig, and M.P. Mattson p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism Ann. Neurol. 52 2002 597 606
35. J.L. Duff, B.P. Monia, and B.C. Berk Mitogen-activated protein (MAP) kinase is regulated by the MAP kinase phosphatase (MKP-1) in vascular smooth muscle cells. Effect of actinomycin D and antisense oligonucleotides J. Biol. Chem. 270 1995 7161 7166
36. H. Elkon, E. Melamed, and D. Offen 6-Hydroxydopamine increases ubiquitin-conjugates and protein degradation: implications for the pathogenesis of Parkinson's disease Cell. Mol. Neurobiol. 21 2001 771 781
37. S. Fahn Description of Parkinson's disease as a clinical syndrome Ann. N. Y. Acad. Sci. 991 2003 1 14
38. J. Fang, T. Akaike, and H. Maeda Antiapoptotic role of heme oxygenase (HO) and the potential of HO as a target in anticancer treatment Apoptosis 9 2004 27 35
39. M. Florio, M.C. Hernandez, H. Yang, H.K. Shu, J.L. Cleveland, and M.A. Israel Id2 promotes apoptosis by a novel mechanism independent of dimerization to basic helix-loop-helix factors Mol. Cell. Biol. 18 1998 5435 5444
40. C.C. Franklin, S. Srikanth, and A.S. Kraft Conditional expression of mitogen-activated protein kinase phosphatase-1, MKP-1, is cytoprotective against UV-induced apoptosis Proc. Natl. Acad. Sci. U. S. A. 95 1998 3014 3019
41. A. Ganguly, T.F. Oo, M. Rzhetskaya, R. Pratt, O. Yarygina, T. Momoi, N. Kholodilov, and R.E. Burke CEP11004, a novel inhibitor of the mixed lineage kinases, suppresses apoptotic death in dopamine neurons of the substantia nigra induced by 6-hydroxydopamine J. Neurochem. 88 2004 469 480
42. D. Ganoth, G. Bornstein, T.K. Ko, B. Larsen, M. Tyers, M. Pagano, and A. Hershko The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27 Nat. Cell Biol. 3 2001 321 324
43. O. Ghribi, M.M. Herman, P. Pramoonjago, and J. Savory MPP+ induces the endoplasmic reticulum stress response in rabbit brain involving activation of the ATF-6 and NF-kappaB signaling pathways J. Neuropathol. Exp. Neurol. 62 2003 1144 1153
44. A. Giaccia, B.G. Siim, and R.S. Johnson HIF-1 as a target for drug development Nat. Rev., Drug Discov. 2 2003 803 811
45. M. Gleichmann, G. Buchheim, H. El-Bizri, Y. Yokota, T. Klockgether, S. Kugler, M. Bahr, M. Weller, and J.B. Schulz Identification of inhibitor-of-differentiation 2 (Id2) as a modulator of neuronal apoptosis J. Neurochem. 80 2002 755 762
46. Y.Y. Glinka, and M.B. Youdim Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine Eur. J. Pharmacol. 292 1995 329 332
47. Y. Glinka, M. Gassen, and M.B. Youdim Mechanism of 6-hydroxydopamine neurotoxicity J. Neural Transm., Suppl. 50 1997 55 66
48. L.A. Greene, and A.S. Tischler Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor Proc. Natl. Acad. Sci. U. S. A. 73 1976 2424 2428
49. L.A. Greene, S.C. Biswas, and D.X. Liu Cell cycle molecules and vertebrate neuron death: E2F at the hub Cell Death Differ. 11 2004 49 60
50. T. Hai, C.D. Wolfgang, D.K. Marsee, A.E. Allen, and U. Sivaprasad ATF3 and stress responses Gene Expression 7 1999 321 335
51. J. Ham, A. Eilers, J. Whitfield, S.J. Neame, and B. Shah c-Jun and the transcriptional control of neuronal apoptosis Biochem. Pharmacol. 60 2000 1015 1021
52. J. Han, C. Flemington, A.B. Houghton, Z. Gu, G.P. Zambetti, R.J. Lutz, L. Zhu, and T. Chittenden Expression of bbc3, a pro-apoptotic BH3-only gene, is regulated by diverse cell death and survival signals Proc. Natl. Acad. Sci. U. S. A. 98 2001 11318 11323
53. B.S. Han, H.S. Hong, W.S. Choi, G.J. Markelonis, T.H. Oh, and Y.J. Oh Caspase-dependent and -independent cell death pathways in primary cultures of mesencephalic dopaminergic neurons after neurotoxin treatment J. Neurosci. 23 2003 5069 5078
54. A. Hartmann, A. Mouatt-Prigent, B.A. Faucheux, Y. Agid, and E.C. Hirsch FADD: a link between TNF family receptors and caspases in Parkinson's disease Neurology 58 2002 308 310
55. M. Hashimoto, E. Rockenstein, L. Crews, and E. Masliah Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases Neuromol. Med. 4 2003 21 36
56. C. Hertzman, M. Wiens, D. Bowering, B. Snow, and D. Calne Parkinson's disease: a case-control study of occupational and environmental risk factors Am. J. Ind. Med. 17 1990 349 355
57. Y. Higashi, M. Asanuma, I. Miyazaki, M.E. Haque, N. Fujita, K. Tanaka, and N. Ogawa The p53-activated gene, PAG608, requires a zinc finger domain for nuclear localization and oxidative stress-induced apoptosis J. Biol. Chem. 277 2002 42224 42232
58. D.D. Hirsch, and P.J. Stork Mitogen-activated protein kinase phosphatases inactivate stress-activated protein kinase pathways in vivo J. Biol. Chem. 272 1997 4568 4575
59. W.A. Holtz, and K.L. O'Malley Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons J. Biol. Chem. 278 2003 19367 19377
60. S.I. Hsu, C.M. Yang, K.G. Sim, D.M. Hentschel, E. O'Leary, and J.V. Bonventre TRIP-Br: a novel family of PHD zinc finger- and bromodomain- interacting proteins that regulate the transcriptional activity of E2F-1/DP-1 EMBO J. 20 2001 2273 2285
61. J.P. Hubble, T. Cao, R.E. Hassanein, J.S. Neuberger, and W.C. Koller Risk factors for Parkinson's disease Neurology 43 1993 1693 1697
62. Y. Imai, M. Soda, H. Inoue, N. Hattori, Y. Mizuno, and R. Takahashi An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin Cell 105 2001 891 902
63. H. Ischiropoulos, and J.S. Beckman Oxidative stress and nitration in neurodegeneration: cause, effect, or association? J. Clin. Invest. 111 2003 163 169
64. Y. Itano, Y. Kitamura, and Y. Nomura 1-Methyl-4-phenylpyridinium (MPP+)-induced cell death in PC12 cells: inhibitory effects of several drugs Neurochem. Int. 25 1994 419 424
65. M. Ivan, K. Kondo, H. Yang, W. Kim, J. Valiando, M. Ohh, A. Salic, J.M. Asara, W.S. Lane, and W.G. Kaelin Jr. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing Science 292 2001 464 468
66. S. Iwata, M. Nomoto, H. Morioka, and A. Miyata Gene expression profiling in the midbrain of striatal 6-hydroxydopamine-injected mice Synapse 51 2004 279 286
67. E. Jarosch, U. Lenk, and T. Sommer Endoplasmic reticulum-associated protein degradation Int. Rev. Cytol. 223 2003 39 81
68. J.R. Jeffers, E. Parganas, Y. Lee, C. Yang, J. Wang, J. Brennan, K.H. MacLean, J. Han, T. Chittenden, and J.N. Ihle Puma is an essential mediator of p53-dependent and -independent apoptotic pathways Cancer Cell 4 2003 321 328
69. P. Jenner Oxidative stress in Parkinson's disease Ann. Neurol. 53 Suppl 3 2003 S26 36 (discussion S36-28)
70. X. Jiang, H.E. Kim, H. Shu, Y. Zhao, H. Zhang, J. Kofron, J. Donnelly, D. Burns, S.C. Ng, S. Rosenberg, and X. Wang Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway Science 299 2003 223 226
71. H.Y. Jiang, S.A. Wek, B.C. McGrath, D. Lu, T. Hai, H.P. Harding, X. Wang, D. Ron, D.R. Cavener, and R.C. Wek Activating transcription factor 3 is integral to the eukaryotic initiation factor 2 kinase stress response Mol. Cell. Biol. 24 2004 1365 1377
72. D. Kaur, F. Yantiri, S. Rajagopalan, J. Kumar, J.Q. Mo, R. Boonplueang, V. Viswanath, R. Jacobs, L. Yang, and M.F. Beal Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease Neuron 37 2003 899 909
73. J.R. Kim, S.R. Lee, H.J. Chung, S. Kim, S.H. Baek, J.H. Kim, and Y.S. Kim Identification of amyloid beta-peptide responsive genes by cDNA microarray technology: involvement of RTP801 in amyloid beta-peptide toxicity Exp. Mol. Med. 35 2003 403 411
74. K. Kito, E.T. Yeh, and T. Kamitani NUB1, a NEDD8-interacting protein, is induced by interferon and down-regulates the NEDD8 expression J. Biol. Chem. 276 2001 20603 20609
75. S. Klumpp, D. Selke, B. Ahlemeyer, C. Schaper, and J. Krieglstein Relationship between protein phosphatase type-2C activity and induction of apoptosis in cultured neuronal cells Neurochem. Int. 41 2002 251 259
76. S. Klumpp, D. Selke, and J. Krieglstein Protein phosphatase type 2C dephosphorylates BAD Neurochem. Int. 42 2003 555 560
77. Y. Koike, and A. Takahashi Autonomic dysfunction in Parkinson's disease Eur. Neurol. 38 Suppl 2 1997 8 12
78. W. Koller, B. Vetere-Overfield, C. Gray, C. Alexander, T. Chin, J. Dolezal, R. Hassanein, and C. Tanner Environmental risk factors in Parkinson's disease Neurology 40 1990 1218 1221
79. K. Krieglstein, C. Suter-Crazzolara, W.H. Fischer, and K. Unsicker TGF-beta superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity EMBO J. 14 1995 736 742
80. J. Kuai, E. Nickbarg, J. Wooters, Y. Qiu, J. Wang, and L.L. Lin Endogenous association of TRAF2, TRAF3, cIAP1, and Smac with lymphotoxin beta receptor reveals a novel mechanism of apoptosis J. Biol. Chem. 278 2003 14363 14369
81. S.M. Kulich, and C.T. Chu Sustained extracellular signal-regulated kinase activation by 6-hydroxydopamine: implications for Parkinson's disease J. Neurochem. 77 2001 1058 1066
82. J.W. Langston, P. Ballard, J.W. Tetrud, and I. Irwin Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis Science 219 1983 979 980
83. J.W. Langston, L.S. Forno, J. Tetrud, A.G. Reeves, J.A. Kaplan, and D. Karluk Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure Ann. Neurol. 46 1999 598 605
84. S.T. Li, R. Dendi, C. Holmes, and D.S. Goldstein Progressive loss of cardiac sympathetic innervation in Parkinson's disease Ann. Neurol. 52 2002 220 223
85. M. Li, J.Y. Zhou, Y. Ge, L.H. Matherly, and G.S. Wu The phosphatase MKP1 is a transcriptional target of p53 involved in cell cycle regulation J. Biol. Chem. 278 2003 41059 41068
86. A. Liu, G.J. Cerniglia, E.J. Bernhard, and G.C. Prendergast RhoB is required to mediate apoptosis in neoplastically transformed cells after DNA damage Proc. Natl. Acad. Sci. U. S. A. 98 2001 6192 6197
87. S. Ma, J. Charron, and R.L. Erikson Role of Plk2 (Snk) in mouse development and cell proliferation Mol. Cell. Biol. 23 2003 6936 6943
88. M.J. Marti, J. Saura, R.E. Burke, V. Jackson-Lewis, A. Jimenez, M. Bonastre, and E. Tolosa Striatal 6-hydroxydopamine induces apoptosis of nigral neurons in the adult rat Brain Res. 958 2002 185 191
89. D.P. Martin, R.E. Schmidt, P.S. DiStefano, O.H. Lowry, J.G. Carter, and E.M. Johnson Jr. Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation J. Cell Biol. 106 1988 829 844
90. S. Matsuda, J. Rouault, J. Magaud, and C. Berthet In search of a function for the TIS21/PC3/BTG1/TOB family FEBS Lett. 497 2001 67 72
91. K. Mayumi-Matsuda, S. Kojima, H. Suzuki, and T. Sakata Identification of a novel kinase-like gene induced during neuronal cell death Biochem. Biophys. Res. Commun. 258 1999 260 264
92. Y. Mizuno, S. Ohta, M. Tanaka, S. Takamiya, K. Suzuki, T. Sato, H. Oya, T. Ozawa, and Y. Kagawa Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease Biochem. Biophys. Res. Commun. 163 1989 1450 1455
93. E.J. Morris, and H.M. Geller Induction of neuronal apoptosis by camptothecin, an inhibitor of DNA topoisomerase-I: evidence for cell cycle-independent toxicity J. Cell Biol. 134 1996 757 770
94. L.Y. Moy, G.D. Zeevalk, and P.K. Sonsalla Role for dopamine in malonate-induced damage in vivo in striatum and in vitro in mesencephalic cultures J. Neurochem. 74 2000 1656 1665
95. T. Nagatsu, M. Mogi, H. Ichinose, and A. Togari Changes in cytokines and neurotrophins in Parkinson's disease J. Neural Transm. 2000 277 290
96. S. Nakagomi, Y. Suzuki, K. Namikawa, S. Kiryu-Seo, and H. Kiyama Expression of the activating transcription factor 3 prevents c-Jun N-terminal kinase-induced neuronal death by promoting heat shock protein 27 expression and Akt activation J. Neurosci. 23 2003 5187 5196
97. D.T. Ng, E.D. Spear, and P. Walter The unfolded protein response regulates multiple aspects of secretory and membrane protein biogenesis and endoplasmic reticulum quality control J. Cell Biol. 150 2000 77 88
98. T. Nguyen, H.C. Huang, and C.B. Pickett Transcriptional regulation of the antioxidant response element. Activation by Nrf2 and repression by MafK J. Biol. Chem. 275 2000 15466 15473
99. J.A. Nilsson, K.H. Maclean, U.B. Keller, H. Pendeville, T.A. Baudino, and J.L. Cleveland Mnt loss triggers Myc transcription targets, proliferation, apoptosis, and transformation Mol. Cell. Biol. 24 2004 1560 1569
100. H. Nishitoh, A. Matsuzawa, K. Tobiume, K. Saegusa, K. Takeda, K. Inoue, S. Hori, A. Kakizuka, and H. Ichijo ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats Genes Dev. 16 2002 1345 1355
101. M. Nomura, S. Shimizu, T. Sugiyama, M. Narita, T. Ito, H. Matsuda, and Y. Tsujimoto 14-3-3 Interacts directly with and negatively regulates pro-apoptotic Bax J. Biol. Chem. 278 2003 2058 2065
102. M.L. Norris, and D.E. Millhorn Hypoxia-induced protein binding to O2-responsive sequences on the tyrosine hydroxylase gene J. Biol. Chem. 270 1995 23774 23779
103. E.E. Ochu, N.J. Rothwell, and C.M. Waters Caspases mediate 6-hydroxydopamine-induced apoptosis but not necrosis in PC12 cells J. Neurochem. 70 1998 2637 2640
104. F. Oehme, P. Ellinghaus, P. Kolkhof, T.J. Smith, S. Ramakrishnan, J. Hutter, M. Schramm, and I. Flamme Overexpression of PH-4, a novel putative proline 4-hydroxylase, modulates activity of hypoxia-inducible transcription factors Biochem. Biophys. Res. Commun. 296 2002 343 349
105. P. Ofek, D. Ben-Meir, Z. Kariv-Inbal, M. Oren, and S. Lavi Cell cycle regulation and p53 activation by protein phosphatase 2C alpha J. Biol. Chem. 278 2003 14299 14305
106. D. Offen, P.M. Beart, N.S. Cheung, C.J. Pascoe, A. Hochman, S. Gorodin, E. Melamed, R. Bernard, and O. Bernard Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicity Proc. Natl. Acad. Sci. U. S. A. 95 1998 5789 5794
107. M. Ohh, C.W. Park, M. Ivan, M.A. Hoffman, T.Y. Kim, L.E. Huang, N. Pavletich, V. Chau, and W.G. Kaelin Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein Nat. Cell Biol. 2 2000 423 427
108. T.F. Oo, C. Henchcliffe, D. James, and R.E. Burke Expression of c-fos, c-jun, and c-jun N-terminal kinase (JNK) in a developmental model of induced apoptotic death in neurons of the substantia nigra J. Neurochem. 72 1999 557 564
109. R.W. Oppenheim, D. Prevette, M. Tytell, and S. Homma Naturally occurring and induced neuronal death in the chick embryo in vivo requires protein and RNA synthesis: evidence for the role of cell death genes Dev. Biol. 138 1990 104 113
110. D. Ord, and T. Ord Mouse NIPK interacts with ATF4 and affects its transcriptional activity Exp. Cell Res. 286 2003 308 320
111. M. Oren Decision making by p53: life, death and cancer Cell Death Differ. 10 2003 431 442
112. S. Oyadomari, and M. Mori Roles of CHOP/GADD153 in endoplasmic reticulum stress Cell Death Differ. 11 2004 381 389
113. D.S. Park, E.J. Morris, J. Padmanabhan, M.L. Shelanski, H.M. Geller, and L.A. Greene Cyclin-dependent kinases participate in death of neurons evoked by DNA-damaging agents J. Cell Biol. 143 1998 457 467
114. S. Park, I. Hwang, M. Shong, and O.Y. Kwon Identification of genes in thyrocytes regulated by unfolded protein response by using disulfide bond reducing agent of dithiothreitol J. Endocrinol. Invest. 26 2003 132 137
115. W.D. Parker Jr., S.J. Boyson, and J.K. Parks Abnormalities of the electron transport chain in idiopathic Parkinson's disease Ann. Neurol. 26 1989 719 723
116. J. Peng, and J.K. Andersen The role of c-Jun N-terminal kinase (JNK) in Parkinson's disease IUBMB Life 55 2003 267 271
117. T.L. Perry, and V.W. Yong Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients Neurosci. Lett. 67 1986 269 274
118. S. Pervin, R. Singh, W.A. Freije, and G. Chaudhuri MKP-1-induced dephosphorylation of extracellular signal-regulated kinase is essential for triggering nitric oxide-induced apoptosis in human breast cancer cell lines: implications in breast cancer Cancer Res. 63 2003 8853 8860
119. M. Pignatelli, R. Luna-Medina, A. Perez-Rendon, A. Santos, and A. Perez-Castillo The transcription factor early growth response factor-1 (EGR-1) promotes apoptosis of neuroblastoma cells Biochem. J. 373 2003 739 746
120. H. Puthalakath, and A. Strasser Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins Cell Death Differ. 9 2002 505 512
121. R.V. Rao, K.S. Poksay, S. Castro-Obregon, B. Schilling, R.H. Row, G. del Rio, B.W. Gibson, H.M. Ellerby, and D.E. Bredesen Molecular components of a cell death pathway activated by endoplasmic reticulum stress J. Biol. Chem. 279 2004 177 187
122. C. Reimertz, D. Kogel, A. Rami, T. Chittenden, and J.H. Prehn Gene expression during ER stress-induced apoptosis in neurons: induction of the BH3-only protein Bbc3/PUMA and activation of the mitochondrial apoptosis pathway J. Cell Biol. 162 2003 587 597
123. A. Ribeiro, S.F. Bronk, P.J. Roberts, R. Urrutia, and G.J. Gores The transforming growth factor beta(1)-inducible transcription factor TIEG1, mediates apoptosis through oxidative stress Hepatology 30 1999 1490 1497
124. P. Rodriguez, J.E. Vinuela, L. Alvarez-Fernandez, and J. Gomez-Marquez Prothymosin alpha antisense oligonucleotides induce apoptosis in HL-60 cells Cell Death Differ. 6 1999 3 5
125. M. Rosenquist 14-3-3 proteins in apoptosis Braz. J. Med. Biol. Res. 36 2003 403 408
126. P. Rosini, G. De Chiara, P. Bonini, M. Lucibello, M.E. Marcocci, E. Garaci, F. Cozzolino, and M. Torcia Nerve growth factor-dependent survival of CESS B cell line is mediated by increased expression and decreased degradation of MAPK phosphatase 1 J. Biol. Chem. 279 2004 14016 14023
127. W. Roth, F. Stenner-Liewen, K. Pawlowski, A. Godzik, and J.C. Reed Identification and characterization of DEDD2, a death effector domain-containing protein J. Biol. Chem. 277 2002 7501 7508
128. D.T. Rutkowski, and R.J. Kaufman All roads lead to ATF4 Dev. Cell 4 2003 442 444
129. D.T. Rutkowski, and R.J. Kaufman A trip to the ER: coping with stress Trends Cell Biol. 14 2004 20 28
130. E.J. Ryu, H.P. Harding, J.M. Angelastro, O.V. Vitolo, D. Ron, and L.A. Greene Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease J. Neurosci. 22 2002 10690 10698
131. E.J. Ryu, S.C. Biswas, C.N. Park, and L.A. Greene Regulation of BH3-Only Proteins in in Vitro Drug Models of Parkinson disease Paper Presented at: Society for Neuroscience (New Orleans, LA) 2003
132. M.S. Saporito, R.L. Hudkins, and A.C. Maroney Discovery of CEP-1347/KT-7515, an inhibitor of the JNK/SAPK pathway for the treatment of neurodegenerative diseases Prog. Med. Chem. 40 2002 23 62
133. A.H. Schapira, J.M. Cooper, D. Dexter, J.B. Clark, P. Jenner, and C.D. Marsden Mitochondrial complex I deficiency in Parkinson's disease J. Neurochem. 54 1990 823 827
134. H.M. Schipper Heme oxygenase-1: role in brain aging and neurodegeneration Exp. Gerontol. 35 2000 821 830
135. H.M. Schipper, A. Liberman, and E.G. Stopa Neural heme oxygenase-1 expression in idiopathic Parkinson's disease Exp. Neurol. 150 1998 60 68
136. T.A. Seaton, J.M. Cooper, and A.H. Schapira Cyclosporin inhibition of apoptosis induced by mitochondrial complex I toxins Brain Res. 809 1998 12 17
137. K. Seth, A.K. Agrawal, M.H. Aziz, A. Ahmad, Y. Shukla, N. Mathur, and P.K. Seth Induced expression of early response genes/oxidative injury in rat pheochromocytoma (PC12) cell line by 6-hydroxydopamine: implication for Parkinson's disease Neurosci. Lett. 330 2002 89 93
138. D.B. Shachar, N. Kahana, V. Kampel, A. Warshawsky, and M.B. Youdim Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lesion in rats Neuropharmacology 46 2004 254 263
139. T. Shoshani, A. Faerman, I. Mett, E. Zelin, T. Tenne, S. Gorodin, Y. Moshel, S. Elbaz, A. Budanov, and A. Chajut Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis Mol. Cell. Biol. 22 2002 2283 2293
140. R.M. Silva, T.F. Oo, V. Jackson-Lewis, E.J. Ryu, D. Ron, S. Przedborski, L.A. Greene, and R.E. Burke The Dopaminergic Neurotoxins 6-Hydroxydopamine (6-OHDA) and MPTP Induce Expression of CHOP (Gadd153) in Substantia Nigra (SN) In Vivo Paper Presented at: Society for Neuroscience (New Orleans, LA) 2003
141. T.P. Singer, R.R. Ramsay, and B.A. Ackrell Deficiencies of NADH and succinate dehydrogenases in degenerative diseases and myopathies Biochim. Biophys. Acta 1271 1995 211 219
142. P.D. Smith, S.J. Crocker, V. Jackson-Lewis, K.L. Jordan-Sciutto, S. Hayley, M.P. Mount, M.J. O'Hare, S. Callaghan, R.S. Slack, and S. Przedborski Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease Proc. Natl. Acad. Sci. U. S. A. 100 2003 13650 13655
143. E. Sofic, P. Riederer, H. Heinsen, H. Beckmann, G.P. Reynolds, G. Hebenstreit, and M.B. Youdim Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain J. Neural Transm. 74 1988 199 205
144. E. Sofic, K.W. Lange, K. Jellinger, and P. Riederer Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease Neurosci. Lett. 142 1992 128 130
145. J.E. Springer, R.D. Azbill, S.A. Nottingham, and S.E. Kennedy Calcineurin-mediated BAD dephosphorylation activates the caspase-3 apoptotic cascade in traumatic spinal cord injury J. Neurosci. 20 2000 7246 7251
146. J.P. Steiner, G.S. Hamilton, D.T. Ross, H.L. Valentine, H. Guo, M.A. Connolly, S. Liang, C. Ramsey, J.H. Li, and W. Huang Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models Proc. Natl. Acad. Sci. U. S. A. 94 1997 2019 2024
147. M. Tanabe, H. Izumi, T. Ise, S. Higuchi, T. Yamori, K. Yasumoto, and K. Kohno Activating transcription factor 4 increases the cisplatin resistance of human cancer cell lines Cancer Res. 63 2003 8592 8595
148. W.G. Tatton, R. Chalmers-Redman, D. Brown, and N. Tatton Apoptosis in Parkinson's disease: signals for neuronal degradation Ann. Neurol. 53 Suppl 3 2003 S61 S70 (discussion S70-62)
149. G. Thiel, and G. Cibelli Regulation of life and death by the zinc finger transcription factor Egr-1 J. Cell. Physiol. 193 2002 287 292
150. D.J. Thuerauf, L. Morrison, and C.C. Glembotski Opposing roles for ATF6alpha and ATF6beta in ER stress response gene induction J. Biol. Chem. 2004
151. B. Torocsik, J.M. Angelastro, and L.A. Greene The basic region and leucine zipper transcription factor MafK is a new nerve growth factor-responsive immediate early gene that regulates neurite outgrowth J. Neurosci. 22 2002 8971 8980
152. T. Trapp, L. Olah, I. Holker, M. Besselmann, C. Tiesler, K. Maeda, and K.A. Hossmann GTPase RhoB: an early predictor of neuronal death after transient focal ischemia in mice Mol. Cell. Neurosci. 17 2001 883 894
153. S.D. Ugarte, E. Lin, E. Klann, M.J. Zigmond, and R.G. Perez Effects of GDNF on 6-OHDA-induced death in a dopaminergic cell line: modulation by inhibitors of PI3 kinase and MEK J. Neurosci. Res. 73 2003 105 112
154. U. Ungerstedt, T. Ljungberg, and G. Steg Behavioral, physiological, and neurochemical changes after 6-hydroxydopamine-induced degeneration of the nigro-striatal dopamine neurons Adv. Neurol. 5 1974 421 426
155. M. Vairapandi, A.G. Balliet, B. Hoffman, and D.A. Liebermann GADD45b and GADD45g are cdc2/cyclinB1 kinase inhibitors with a role in S and G2/M cell cycle checkpoints induced by genotoxic stress J. Cell. Physiol. 192 2002 327 338
156. V.E. Velculescu, L. Zhang, B. Vogelstein, and K.W. Kinzler Serial analysis of gene expression Science 270 1995 484 487
157. V. Viswanath, Y. Wu, R. Boonplueang, S. Chen, F.F. Stevenson, F. Yantiri, L. Yang, M.F. Beal, and J.K. Andersen Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced Parkinson's disease J. Neurosci. 21 2001 9519 9528
158. T. Wada, and J.M. Penninger Mitogen-activated protein kinases in apoptosis regulation Oncogene 23 2004 2838 2849
159. K. Wakabayashi, and H. Takahashi Neuropathology of autonomic nervous system in Parkinson's disease Eur. Neurol. 38 Suppl 2 1997 2 7
160. G. Walkinshaw, and C.M. Waters Neurotoxin-induced cell death in neuronal PC12 cells is mediated by induction of apoptosis Neuroscience 63 1994 975 987
161. H.G. Wang, N. Pathan, I.M. Ethell, S. Krajewski, Y. Yamaguchi, F. Shibasaki, F. McKeon, T. Bobo, T.F. Franke, and J.C. Reed Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD Science 284 1999 339 343
162. J. Xu, S.Y. Kao, F.J. Lee, W. Song, L.W. Jin, and B.A. Yankner Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease Nat. Med. 8 2002 600 606
163. M.S. Yoo, H.S. Chun, J.J. Son, L.A. DeGiorgio, D.J. Kim, C. Peng, and J.H. Son Oxidative stress regulated genes in nigral dopaminergic neuronal cells: correlation with the known pathology in Parkinson's disease Brain Res., Mol. Brain Res. 110 2003 76 84
164. H.S. Yoon, and V.W. Yang Requirement of Kruppel-like factor 4 in preventing entry into mitosis following DNA damage J. Biol. Chem. 279 2004 5035 5041
165. J. Zha, S. Weiler, K.J. Oh, M.C. Wei, and S.J. Korsmeyer Posttranslational N-myristoylation of BID as a molecular switch for targeting mitochondria and apoptosis Science 290 2000 1761 1765